Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADIOSONIC: Radiotherapy After SHHi in laBCC
NCT05561634Phase 2Recruiting
- Sponsor
- CHU de Lille
- Start
- Jun 2023
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by CHU de Lille. Primary endpoint: Occurrence of a local relapse at 2 years. Started Jun 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05561634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05561634.